Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis
Authors:
Open Access
- 19 March 2025
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0317730
Abstract
Background: Non-alcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC) has been emerging a predominant reason for liver transplantation (LT). The complexity of comorbidities in this population increases the possibility of poor transplant outcomes. The purpose of this study was to evaluate the differences in survival after transplantation among patients with NASH HCC and those with non-NASH HCC. Method: We conducted systematic searches of the PubMed, Embase, Web of Science, and Cochrane Library databases. To analyze the data, both fixed and random-effects models were employed to aggregate hazard ratios (HRs) along with 95% confidence intervals (CIs) for recurrence-free survival (RFS) and overall survival (OS) outcomes. This study is registered with PROSPERO as CRD42024578441. Results: A total of seven studies were included in this study. This study revealed that there was no significant difference in OS between liver transplant recipients with NASH HCC and those with non-NASH HCC. The RFS of NASH HCC patients were significantly longer. The HRs were 0.70 (95% CI: 0.51-0.97, P = 0.03) for RFS and 0.88 (95% CI: 0.72-1.07, P = 0.21) for OS, respectively. Conclusion: This study indicates that patients with NASH HCC who undergo LT have comparable OS as those with non-NASH HCC, while NASH HCC was associated with increased RFS. However, further research in randomized trials is necessary to verify these results and address potential selection biases.Keywords
Funding Information
- National Natural Science Foundation of China (81770566)
- NHC Key Laboratory of Echinococcosis Prevention and Control (2021WZK1004)
- National Natural Science Foundation of China (82000599)
- The Science & Technology Department of Sichuan Province Funding Project (2023YFS0229)
- Health Commission of the Tibet Autonomous Region (311220432)
This publication has 34 references indexed in Scilit:
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver TransplantJAMA Surgery, 2022
- Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinomaDigestive and Liver Disease, 2020
- Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver DiseaseHepatology, 2019
- Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and OutcomesDigestive Diseases and Sciences, 2017
- Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinomaLiver Transplantation, 2017
- Lower rates of receiving model for end‐stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinomaLiver Transplantation, 2016
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009Hepatology, 2015
- Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs PopulationClinical Gastroenterology and Hepatology, 2015
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Hepatology, 2013